Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | CES1 | P23141 | 3/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3518766 | 1.00 | CA1 (0.41) | CA1CA2CES2CES1EPHX1 | |
| SCHEMBL3521472 | 0.93 | CA1 (0.39) | CA1CA2CES2CES1 | |
| SCHEMBL11909931 | 0.84 | CA1 (0.49) | CA1CA2GPR84 | |
| SCHEMBL6661209 | 0.84 | CA1 (0.49) | CA1CA2GPR84 | |
| SCHEMBL3269704 | 0.83 | CA1 (0.48) | CA1CA2CES2CES1EPHX1 | |
| SCHEMBL3520573 | 0.83 | CA1 (0.40) | CA1CA2CES2CES1GPR84 | |
| SCHEMBL3520045 | 0.79 | CA1 (0.38) | CA1CA2 | |
| SCHEMBL4196107 | 0.79 | CA1 (0.52) | CA1CA2CES2CES1EPHX1 | |
| L-Lactic Acid SCHEMBL6072494 | 0.77 | CA1 (0.50) | CA1CA2CES2CES1EPHX1 | |
| SCHEMBL6129212 | 0.77 | FABP3 (0.45) | CA1LMNAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | CHEMTURA CORPORATION (US) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190902-A1 | ALKYLTIN SULFANYL ESTER THIOLS | SULT1E1, SULT1A1, TST | CA1 4793/4885CA2 4833/4885CES2 1052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.